Nelfinavir

In the US, Nelfinavir (nelfinavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection, Nonoccupational Exposure and Occupational Exposure.

US matches:

• Nelfinavir


• Nelfinavir Powder


• Nelfinavir Mesylate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AE04

CAS registry number (Chemical Abstracts Service)

0159989-64-7

Chemical Formula

C32-H45-N3-O4-S

Molecular Weight

567

Therapeutic Category

Antiviral agent, HIV protease inhibitor

Chemical Name

3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-[2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, [3S-[2(2S*,3S*),3α,4aß,8aß]]-

Foreign Names

• Nelfinavirum (Latin)
• Nelfinavir (German)
• Nelfinavir (French)
• Nelfinavir (Spanish)

Generic Names

• Nelfinavir (OS: BAN, DCF)
• AG 1346 (IS: Agouron)
• Nelfinavir Mesylate (OS: USAN)
• AG 1343 (IS: Agouron)
• LY 312857 (IS: Agouron)
• Nelfinavir methanesulfonate (IS)
• Nelfinavir Mesilate (PH: Ph. Int. 4)
• Nelfinaviri mesilas (PH: Ph. Int. 4)

Brand Names

• Elfivir
  Biogen, Peru



• Nelvir
  Biogen, Colombia; Cipla, India



• Retroinhi
  Dosa, Argentina



• Viracept
  Roche, Ireland



• Vira-Cept
  Roche, South Africa



• Avifix
  Beximco, Bangladesh



• Ciplanavir
  Biotoscana, Colombia



• Filosfil
  Filaxis, Argentina



• Nalvir
  Richmond, Argentina



• Nelfilea
  Elea, Argentina



• Nelvir
  Pharmaceutical, Venezuela; Square, Bangladesh



• Viracept
  Agouron, United States; Chugai, Japan; Japan Tobacco, Japan; Pfizer, Canada; Roche, United Arab Emirates; Roche, Argentina; Roche, Bosnia & Herzegowina; Roche, Belgium; Roche, Brazil; Roche, Botswana; Roche, Switzerland; Roche, Chile; Roche, Colombia; Roche, Czech Republic; Roche, Germany; Roche, Ecuador; Roche, Estonia; Roche, Egypt; Roche, Spain; Roche, Ethiopia; Roche, Finland; Roche, France; Roche, United Kingdom; Roche, Georgia; Roche, Ghana; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Hungary; Roche, Israel; Roche, Iceland; Roche, Italy; Roche, Kenya; Roche, Cambodia; Roche, Kazakhstan; Roche, Laos; Roche, Luxembourg; Roche, Morocco; Roche, Malawi; Roche, Mexico; Roche, Malaysia; Roche, Namibia; Roche, Nigeria; Roche, Netherlands; Roche, Oman; Roche, Peru; Roche, Philippines; Roche, Poland; Roche, Portugal; Roche, Paraguay; Roche, Qatar; Roche, Romania; Roche, Serbia; Roche, Russian Federation; Roche, Sudan; Roche, Singapore; Roche, Slovenia; Roche, Slovakia; Roche, Thailand; Roche, Taiwan; Roche, Tanzania; Roche, Uganda; Roche, Uruguay; Roche, Venezuela; Roche, Zambia; Roche, Zimbabwe; ViiV Healthcare, United States

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Hya-ject

Hya-ject may be available in the countries listed below.

Ingredient matches for Hya-ject

Hyaluronic Acid

Hyaluronic Acid sodium salt (a derivative of Hyaluronic Acid) is reported as an ingredient of Hya-ject in the following countries:

• Germany

International Drug Name Search

Fumarton

Fumarton may be available in the countries listed below.

Ingredient matches for Fumarton

Ketotifen

Ketotifen fumarate (a derivative of Ketotifen) is reported as an ingredient of Fumarton in the following countries:

• Japan

International Drug Name Search

Sandimmune

Sandimmune is a brand name of cyclosporine, approved by the FDA in the following formulation(s):

SANDIMMUNE (cyclosporine - capsule; oral)

• 
  Manufacturer: NOVARTIS
  
  Approval date: March 2, 1990
  
  Strength(s): 100MG ^[RLD][AB2], 25MG ^[AB2]

SANDIMMUNE (cyclosporine - injectable; injection)

• 
  Manufacturer: NOVARTIS
  
  Approval date: November 14, 1983
  
  Strength(s): 50MG/ML ^[RLD][AP]

SANDIMMUNE (cyclosporine - solution; oral)

• 
  Manufacturer: NOVARTIS
  
  Approval date: November 14, 1983
  
  Strength(s): 100MG/ML ^[RLD][AB2]

Has a generic version of Sandimmune been approved?

Yes. The following products are equivalent to Sandimmune:

cyclosporine capsule; oral

• 
  Manufacturer: APOTEX
  
  Approval date: May 9, 2002
  
  Strength(s): 100MG ^[AB2], 25MG ^[AB2]

cyclosporine injectable; injection

• 
  Manufacturer: BEDFORD
  
  Approval date: October 29, 1999
  
  Strength(s): 50MG/ML ^[AP]


• 
  Manufacturer: LUITPOLD
  
  Approval date: October 7, 2003
  
  Strength(s): 50MG/ML ^[AP]

cyclosporine solution; oral

• 
  Manufacturer: WOCKHARDT
  
  Approval date: September 17, 2004
  
  Strength(s): 100MG/ML ^[AB2]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Sandimmune. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Sandimmune.

See also...

• Sandimmune Consumer Information (Wolters Kluwer)
• Sandimmune Soft Gelatin Capsules Consumer Information (Wolters Kluwer)
• Sandimmune Solution Consumer Information (Wolters Kluwer)
• Sandimmune Consumer Information (Cerner Multum)
• Sandimmune Advanced Consumer Information (Micromedex)
• Cyclosporine Consumer Information (Wolters Kluwer)
• Cyclosporine Capsules Consumer Information (Wolters Kluwer)
• Cyclosporine Soft Gelatin Capsules Consumer Information (Wolters Kluwer)
• Cyclosporine Solution Consumer Information (Wolters Kluwer)
• Cyclosporine Consumer Information (Cerner Multum)
• Apo-Cyclosporine Advanced Consumer Information (Micromedex)
• Cyclosporine Oral, Intravenous Advanced Consumer Information (Micromedex)
• Cyclosporine AHFS DI Monographs (ASHP)

Amicasil

Amicasil may be available in the countries listed below.

Ingredient matches for Amicasil

Amikacin

Amikacin sulfate (a derivative of Amikacin) is reported as an ingredient of Amicasil in the following countries:

• Greece


• Italy

International Drug Name Search

Entact Paranova

Entact Paranova may be available in the countries listed below.

Ingredient matches for Entact Paranova

Escitalopram

Escitalopram oxalate (a derivative of Escitalopram) is reported as an ingredient of Entact Paranova in the following countries:

• Denmark

International Drug Name Search

Roug-Mycin

Roug-Mycin may be available in the countries listed below.

Ingredient matches for Roug-Mycin

Erythromycin

Erythromycin stearate (a derivative of Erythromycin) is reported as an ingredient of Roug-Mycin in the following countries:

• Greece

International Drug Name Search